The global investigational new drug CDMO market size is expected to reach USD 6.8 billion by 2028, according to a new report by the publisher It is expected to expand at a CAGR of 6.9% from 2021 to 2028. This is largely due to the increased R&D investments, along with stringent regulations pertaining to IND.
The U.S. FDA and the European Medicines Agency (EMA) are health authority bodies that regulate the use of investigational drugs in the U.S. and the European Union, respectively. In addition, investigational review boards (IRBs) in the U.S. and ethics committees (ECs) in the European Union must approve the use of drugs in humans.
It is the requirement of a federal law that a drug be the subject of an approved marketing application prior to it is distributed or transported across the state lines. Hence, sponsors aiming to conduct clinical studies that involve an IND should gain exemption from the FDA to permit the shipping of the investigational drug to clinical investigators in several states.
The pandemic has significantly impacted the global economy in 2020 and has an ongoing impact on various industries. However, the market for IND CDMO has benefited from the pandemic. Prior to COVID-19, prospective sponsors demanded facility audits to ensure CDMOs had the required capacity, equipment, and personnel to undertake their projects. Nowadays, CDMOs should find new ways to attract new sponsors, such as through videos, virtual reality, and other technologies that allow sponsors to virtually experience the site.
This product will be delivered within 1-3 business days.
The U.S. FDA and the European Medicines Agency (EMA) are health authority bodies that regulate the use of investigational drugs in the U.S. and the European Union, respectively. In addition, investigational review boards (IRBs) in the U.S. and ethics committees (ECs) in the European Union must approve the use of drugs in humans.
It is the requirement of a federal law that a drug be the subject of an approved marketing application prior to it is distributed or transported across the state lines. Hence, sponsors aiming to conduct clinical studies that involve an IND should gain exemption from the FDA to permit the shipping of the investigational drug to clinical investigators in several states.
The pandemic has significantly impacted the global economy in 2020 and has an ongoing impact on various industries. However, the market for IND CDMO has benefited from the pandemic. Prior to COVID-19, prospective sponsors demanded facility audits to ensure CDMOs had the required capacity, equipment, and personnel to undertake their projects. Nowadays, CDMOs should find new ways to attract new sponsors, such as through videos, virtual reality, and other technologies that allow sponsors to virtually experience the site.
Investigational New Drug CDMO Market Report Highlights
- In terms of product, the small molecule segment dominated the market with a revenue share of 89.0% in 2020. This is largely due to the increasing number of small molecules in development. Besides, in 2019, the small molecules dominated the new drug approvals accounting for 79% of all the NME approvals
- Based on service, the contract development segment led the market with a revenue share of 85.5% in 2020. The contract development offers several benefits over in-house development of drugs, such as access to industry experts, less time to market, cost-effectiveness, and more focus on core competencies
- By end user, pharmaceutical companies accounted for the largest share of 69.4% in 2020. This is due to the changes in the pharmaceutical industry that have an impact on research and development strategies, which, in turn, influence new drug approval trends
- Asia Pacific to register the fastest growth rate of 7.7% over the forecast period. Due to the rapid growth of pharmaceutical firms and contract manufacturing organizations in developing countries, such as India and China, the region is likely to overtake Europe and North America in the near future
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Methodology and Scope1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Region Wise Market Calculation
1.6.1 Region Wise Market: Base Estimates
1.6.2 Global Market: CAGR Calculation
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective - 1: Understanding market dynamics
1.8.2 Objective - 2: Understanding market estimates and forecasts
1.8.3 Objective - 3: Understanding attributes such as strategy framework and competitor categorization
1.8.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size.
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Global IND CDMO Market: Variables, Trends, & Scope
3.1 Market Segmentation and Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing outsourcing services by pharmaceutical companies
3.2.1.2 Rising investment in R&D
3.2.1.3 Growing pharmaceutical industry
3.2.1.5 Stringent regulatory requirements
3.2.2 Market Restraint Analysis
3.2.2.1 Compliance issues while outsourcing
3.2.2.2 Changing scenario in developing countries
3.3 Penetration & Growth Prospect Mapping
3.4 COVID-19 Impact on the Market
3.5 Major Deals and Strategic Alliances Analysis
3.6 Global IND CDMO: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s
3.6.3 PESTEL Analysis
Chapter 4 Global IND CDMO Market: Product Segment Analysis
4.1 Global IND CDMO Market: Product Market Share Analysis, 2020 & 2028
4.2 Small Molecule
4.2.1 Small Molecule Market, 2016 - 2028 (USD Million)
4.3 Large Molecule
4.3.1 Large Molecule Market, 2016 - 2028 (USD Million)
Chapter 5 Global IND CDMO Market: Service Segment Analysis
5.1 Global IND CDMO Market: Service Market Share Analysis, 2020 & 2028
5.2 Contract Development
5.2.1 Contract Development market, 2016 - 2028 (USD Million)
5.2.2 Small Molecule
5.2.2.1 Small Molecule market, 2016 - 2028 (USD Million)
5.2.2.2.1 Bioanalysis and DMPK studies
5.2.2.2.2 Bioanalysis and DMPK studies market, 2016 - 2028 (USD Million)
5.2.2.2.3 Toxicology Testing
5.2.2.2.4 Toxicology Testing market, 2016 - 2028 (USD Million)
5.2.2.2.5 Pathology and safety pharmacology studies
5.2.2.2.6 Pathology and safety pharmacology studies market, 2016 - 2028 (USD Million)
5.2.2.2.7 Drug substance synthetic route development
5.2.2.2.8 Drug substance synthetic route development market, 2016 - 2028 (USD Million)
5.2.2.2.9 Drug substance process development
5.2.2.2.10 Drug substance process development market, 2016 - 2028 (USD Million)
5.2.2.2.11 Drug substance synthetic route development
5.2.2.2.12 Drug substance synthetic route development market, 2016 - 2028 (USD Million)
5.2.2.2.13 Form selection crystallization process development
5.2.2.2.14 Form selection crystallization process development market, 2016 - 2028 (USD Million)
5.2.2.2.15 Scale up of drug substance
5.2.2.2.16 Scale up of drug substance market, 2016 - 2028 (USD Million)
5.2.2.2.17 Preformulation
5.2.2.2.18 Preformulation market, 2016 - 2028 (USD Million)
5.2.2.2.19 Preclinical formulation selection
5.2.2.2.20 Preclinical formulation selection market, 2016 - 2028 (USD Million)
5.2.2.2.21 First in Man Formulation/ Process Development
5.2.2.2.22 First in Man Formulation/ Process Development market, 2016 - 2028 (USD Million)
5.2.2.2.23 Analytical method development / validation
5.2.2.2.24 Analytical method development / validation market, 2016 - 2028 (USD Million)
5.2.2.2.25 Release testing of drug substance and drug product
5.2.2.2.25 Release testing of drug substance and drug product market, 2016 - 2028 (USD Million)
5.2.2.2.26 Work up Purification Steps
5.2.2.2.27 Work up purification steps market, 2016 - 2028 (USD Million)
5.2.2.2.28 Telescoping & Process Refining
5.2.2.2.29 Telescoping & Process Refining market, 2016 - 2028 (USD Million)
5.2.2.2.30 Initial Optimization
5.2.2.2.31 Initial Optimization market, 2016 - 2028 (USD Million)
5.2.2.2.32 Formal stability of drug substance and drug product
5.2.2.2.33 Formal stability of drug substance and drug product market, 2016 - 2028 (USD Million)
5.2.3 Large Molecule
5.2.3.1 Large Molecule market, 2016 - 2028 (USD Million)
5.2.3.2 Cell Line development
5.2.3.3 Cell line development market, 2016 - 2028 (USD Million)
5.2.3.4 Process development
5.2.3.5 Process development market, 2016 - 2028 (USD Million)
5.2.3.4.1 Upstream
5.2.3.4.1.1 Upstream market, 2016 - 2028 (USD Million)
5.2.3.4.1.2 Microbial
5.2.3.4.1.3 Microbial market, 2016 - 2028 (USD Million)
5.2.3.4.1.4 Mammalian
5.2.3.4.1.5 Mammalian market, 2016 - 2028 (USD Million)
5.2.3.4.1.6 Others
5.2.3.4.1.7 Others market, 2016 - 2028 (USD Million)
5.2.3.4.1.8 Upstream
5.2.3.4.1.9 Upstream market, 2016 - 2028 (USD Million)
5.2.3.4.2 Downstream
5.2.3.4.2.1 Downstream market, 2016 - 2028 (USD Million)
5.2.3.4.2.2 MABs
5.2.3.4.2.3 MABs market, 2016 - 2028 (USD Million)
5.2.3.4.2.4 Recombinant Proteins
5.2.3.4.2.5 Recombinant Proteins market, 2016 - 2028 (USD Million)
5.2.3.4.2.6 Others
5.2.3.4.2.7 Others market, 2016 - 2028 (USD Million)
5.3 Contract Manufacturing
5.3.1 Contract Manufacturing market, 2016 - 2028 (USD Million)
5.3.1.1 Small Molecule
5.3.1.2 Small Molecule market, 2016 - 2028 (USD Million)
5.3.1.1.1 Oral Solids
5.3.1.1.2 Oral Solids market, 2016 - 2028 (USD Million)
5.3.1.1.1 Liquid & Semi-solids
5.3.1.1.2 Liquid & Semi-solids market, 2016 - 2028 (USD Million)
5.3.1.1.3 InjecTables
5.3.1.1.4 InjecTables market, 2016 - 2028 (USD Million)
5.3.1.1.5 Others
5.3.1.1.6 Others market, 2016 - 2028 (USD Million)
5.3.2 Large Molecule
5.3.2.1 Large Molecule market, 2016 - 2028 (USD Million)
5.3.2.1.1 MABs
5.3.2.1.2 MABs market, 2016 - 2028 (USD Million)
5.3.2.1.3 Recombinant Proteins
5.3.2.1.4 Recombinant Proteins market, 2016 - 2028 (USD Million)
5.3.2.1.5 MABs
5.3.2.1.6 MABs market, 2016 - 2028 (USD Million)
5.3.2.1.7 Others
5.3.2.1.8 Others market, 2016 - 2028 (USD Million)
Chapter 6 Global IND CDMO Market: End-user Segment Analysis
6.1 Global IND CDMO Market: End-user Market Share Analysis, 2020 & 2028
6.2 Pharmaceutical Companies
6.2.1 Pharmaceutical companies IND CDMO Market, 2016 - 2028 (USD Million)
6.3 Biotech
6.3.2. Biotech Companies IND CDMO Market, 2016 - 2028 (USD Million)
6.4 Others
6.4.2. Others IND CDMO Market, 2016 - 2028 (USD Million)
Chapter 7 Global IND CDMO Market: Regional Analysis
7.1 Global IND CDMO Market: Regional Market Share Analysis, 2020 & 2028
7.2 North America
7.2.1 North America IND CDMO Market, 2016 - 2028 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. IND CDMO Market, 2016 - 2028 (USD Million)
7.2.3 Canada
7.2.3.1 Canada IND CDMO Market, 2016 - 2028 (USD Million)
7.3 Europe
7.3.1 Europe IND CDMO Market, 2016 - 2028 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. IND CDMO Market, 2016 - 2028 (USD Million)
7.3.3 Germany
7.3.3.1 Germany IND CDMO Market, 2016 - 2028 (USD Million)
7.3.4 France
7.3.4.1 France IND CDMO Market, 2016 - 2028 (USD Million)
7.3.5 Italy
7.3.5.1 Italy IND CDMO Market, 2016 - 2028 (USD Million)
7.3.6 Spain
7.3.6.1 Spain IND CDMO Market, 2016 - 2028 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific IND CDMO Market, 2016 - 2028 (USD Million)
7.4.2 Japan
7.4.2.1 Japan IND CDMO Market, 2016 - 2028 (USD Million)
7.4.3 China
7.4.3.1 China IND CDMO Market, 2016 - 2028 (USD Million)
7.4.4 India
7.4.4.1 India IND CDMO Market, 2016 - 2028 (USD Million)
7.4.5 Australia
7.4.5.1 Australia IND CDMO Market, 2016 - 2028 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea IND CDMO Market, 2016 - 2028 (USD Million)
7.5 Latin America
7.5.1 Latin America IND CDMO Market, 2016 - 2028 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil IND CDMO Market, 2016 - 2028 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico IND CDMO Market, 2016 - 2028 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina IND CDMO Market, 2016 - 2028 (USD Million)
7.6 MEA
7.6.1 MEA IND CDMO Market, 2016 - 2028 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa IND CDMO Market, 2016 - 2028 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia IND CDMO Market, 2016 - 2028 (USD Million)
7.6.4 UAE
7.6.4.1 UAE IND CDMO Market, 2016 - 2028 (USD Million)
Chapter 8 Company Profiles
8.1 Catalent, Inc.
8.1.1 Company Overview
8.1.2 Service Benchmarking
8.1.3 Financial Performance
8.1.4 Strategic Initiatives
8.2 Lonza
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Service Benchmarking
8.2.5 Strategic Initiatives
8.3 Recipharm AB
8.3.1 Company Overview
8.3.2 Service Benchmarking
8.3.3 Strategic Initiatives
8.4 Siegfried Holding AG
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Service Benchmarking
8.5 Patheon Inc.
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Service Benchmarking
8.6 Covance
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Service Benchmarking
8.7 IQVIA Holdings Inc.
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Service Benchmarking
8.7.4 Strategic Initiatives
8.8 Cambrex Corporation
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Service Benchmarking
8.9 Charles River Laboratories International, Inc.
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Service Benchmarking
8.9.4 Strategic Initiatives
8.10 Syneous Health
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Service Benchmarking
8.10.4 Strategic InitiativesList of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global IND CDMO Market, by region 2016 - 2028 (USD Million)
Table 4 Global IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 5 Global IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 6 Global IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 7 North America IND CDMO Market, by Country 2016 - 2028 (USD Million)
Table 8 North America IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 9 North America IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 10 North America IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 11 U.S. IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 12 U.S. IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 13 U.S. IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 14 Canada IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 15 Canada IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 16 Canada IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 17 Europe IND CDMO Market, by Country 2016 - 2028 (USD Million)
Table 18 Europe IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 19 Europe IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 20 Europe IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 21 U.K.IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 22 U.K. IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 23 U.K. IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 24 Germany IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 25 Germany IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 26 Germany IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 27 France IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 28 France IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 29 France IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 30 Italy IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 31 Italy IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 32 Italy IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 33 Spain IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 34 Spain IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 35 Spain IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 36 Asia Pacific IND CDMO Market, by Country 2016 - 2028 (USD Million)
Table 37 Asia Pacific IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 38 Asia Pacific IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 39 Asia Pacific IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 40 China IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 41 China IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 42 China IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 43 Japan IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 44 Japan IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 45 Japan IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 46 India IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 47 India IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 48 India IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 49 Australia IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 50 Australia IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 51 Australia IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 52 South Korea IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 53 South Korea IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 54 South Korea IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 55 Latin America IND CDMO Market, by Country 2016 - 2028 (USD Million)
Table 56 Latin America IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 57 Latin America IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 58 Latin America IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 59 Brazil IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 60 Brazil IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 61 Brazil IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 62 Mexico IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 63 Mexico IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 64 Mexico IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 65 Argentina IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 66 Argentina IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 67 Argentina IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 68 MEA IND CDMO Market, by Country 2016 - 2028 (USD Million)
Table 69 MEA IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 70 MEA IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 71 MEA IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 72 South Africa IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 73 South Africa IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 74 South Africa IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 75 South Arabia IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 76 South Arabia IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 77 South Arabia IND CDMO Market, by End User 2016 - 2028 (USD Million)
Table 78 UAE IND CDMO Market, by Product 2016 - 2028 (USD Million)
Table 79 UAE IND CDMO Market, by Service 2016 - 2028 (USD Million)
Table 80 UAE IND CDMO Market, by End User 2016 - 2028 (USD Million)
List of Figures
Figure. 1 Market research process
Figure. 2 Information procurement
Figure. 3 Secondary research pattern
Figure. 4 Market research approaches
Figure. 5 QFD modeling for market share assessment
Figure. 6 Market formulation & validation
Figure. 7 Global IND CDMO market snapshot (2020)
Figure. 8 Global IND CDMO market segmentation
Figure. 9 Market driver relevance analysis (Current & future impact)
Figure. 10 Market restraint relevance analysis (Current & future impact)
Figure. 11 Penetration & growth prospect mapping
Figure. 12 Porter’s five forces analysis
Figure. 13 PESTEL analysis
Figure. 14 Global IND CDMO market product outlook: Segment dashboard
Figure. 15 Global IND CDMO market: Product movement analysis
Figure. 16 Small Molecule market, 2016 - 2028 (USD Million)
Figure. 17 Large Molecule market, 2016 - 2028 (USD Million)
Figure. 18 Global IND CDMO market service outlook: Segment dashboard
Figure. 19 Global IND CDMO market: Service movement analysis
Figure. 20 Contract Development market, 2016 - 2028 (USD Million)
Figure. 21 Contract Manufacturing market, 2016 - 2028 (USD Million)
Figure. 22 Global IND CDMO market end-user outlook: Segment dashboard
Figure. 23 Global IND CDMO market: End-user movement analysis
Figure. 24 Pharmaceutical companies market, 2016-2028 (USD Million)
Figure. 25 Biotech companies market, 2016 - 2028 (USD Million)
Figure. 26 Others market, 2016 - 2028 (USD Million)
Figure. 27 Regional market: Key takeaways
Figure. 28 Regional outlook, 2020 & 2028
Figure. 29 North America market, 2016 - 2028 (USD Million)
Figure. 30 U.S. market, 2016 - 2028 (USD Million)
Figure. 31 Canada market, 2016 - 2028 (USD Million)
Figure. 32 Europe market, 2016 - 2028 (USD Million)
Figure. 33 U.K. market, 2016 - 2028 (USD Million)
Figure. 34 Germany market, 2016 - 2028 (USD Million)
Figure. 35 France market, 2016 - 2028 (USD Million)
Figure. 36 Italy market, 2016 - 2028 (USD Million)
Figure. 37 Spain market, 2016 - 2028 (USD Million)
Figure. 38 Asia Pacific market, 2016 - 2028 (USD Million)
Figure. 39 Japan market, 2016 - 2028 (USD Million)
Figure. 40 China market, 2016 - 2028 (USD Million)
Figure. 41 India market, 2016 - 2028 (USD Million)
Figure. 42 Australia market, 2016 - 2028 (USD Million)
Figure. 43 South Korea market, 2016 - 2028 (USD Million)
Figure. 44 Latin America market, 2016 - 2028 (USD Million)
Figure. 45 Brazil market, 2016 - 2028 (USD Million)
Figure. 46 Mexico market, 2016 - 2028 (USD Million)
Figure. 47 Argentina market, 2016 - 2028 (USD Million)
Figure. 48 MEA market, 2016 - 2028 (USD Million)
Figure. 49 South Africa market, 2016 - 2028 (USD Million)
Figure. 50 Saudi Arabia market, 2016 - 2028 (USD Million)
Figure. 51 UAE market, 2016 - 2028 (USD Million)
Companies Mentioned
- Catalent, Inc.
- Lonza
- Recipharm AB
- Siegfried Holding AG
- Patheon Inc.
- Covance
- IQVIA Holdings Inc.
- Cambrex Corporation
- Charles River Laboratories International, Inc.
- Syneous Health
Methodology
LOADING...
